Skip to main content
. 2019 Jan 10;2019:4081962. doi: 10.1155/2019/4081962

Figure 3.

Figure 3

Serum uric acid (SUA) in patients with breast tumors (mean ± SD). The level of SUA before treatment in patients with malignant breast tumor (breast cancer) was higher than that in patients with benign breast tumor. (a) Benign group (n = 100) and malignant group (n = 203), P ≤ 0.001, independent samples t-test. When patients with breast cancer are treated with chemotherapeutics, the level of SUA further increased. (b) n = 203, P ≤ 0.001, paired t-test.